SS
DRUG

Steve Schonfeld’s Bright Minds Biosciences DRUG Stock Holding History

Steve Schonfeld’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.65M Buy
66,277
+53,033
+400% +$4.16M 0.02% 669
2026
Q1 		$966K Sell
13,244
-16,967
-56% -$1.37M 0.01% 1115
2025
Q4 		$2.36M Sell
30,211
-36,395
-55% -$2.43M 0.01% 816
2025
Q3 		$4.04M Sell
66,606
-2,398
-3% -$93.1K 0.02% 681
2025
Q2 		$1.8M Sell
69,004
-6,597
-9% -$198K 0.01% 1040
2025
Q1 		$2.72M Buy
75,601
+5,789
+8% +$212K 0.02% 807
2024
Q4 		$2.46M Buy
+69,812
New +$2.46M 0.01% 751

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Steve Schonfeld's DRUG Position: Q2 2026 in Review

Steve Schonfeld increased its Bright Minds Biosciences (DRUG) stake by 400% in Q2 2026, buying an estimated $4.16M and bringing the position to 66,277 shares worth $4.65M. The position accounts for 0.02% of the portfolio, ranked #669.

Steve Schonfeld first reported a position in DRUG in Q4 2024 and has held it in 7 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Steve Schonfeld held 66,277 shares of Bright Minds Biosciences worth $4.65M as of Q2 2026.
  • Steve Schonfeld bought 53,033 Bright Minds Biosciences shares in Q2 2026, an estimated $4.16M.
  • Bright Minds Biosciences made up 0.02% of Steve Schonfeld's portfolio in Q2 2026, its #669 holding.
  • Steve Schonfeld first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.